| Factor Information | |
|---|---|
| Data ID | 3809 |
| Factor | mid-diastolic flow reversal |
| Description | Preoperative mid-diastolic flow reversal of mitral inflow was observed in 5 of 40 patients; 1 patient with aortic stenosis and 4 patients with coarctation of the aorta. |
| Biomarker | YES |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis and risk assessment |
| Objective | To determine whether mid-diastolic flow reversal predicts outcome in patients undergoing repair or palliation of neonatal congenital heart disease |
| Conclusion | Preoperative mid-diastolic flow reversal of mitral inflow was observed in 5 of 40 patients; 1 patient with aortic stenosis and 4 patients with coarctation of the aorta. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 711 |
| CHD Type | isolated CHD |
| CHD Subtype | TGA/CoA/IAA/AS |
| Reference | |
|---|---|
| PMID | 9842023 |
| Year | 1998 |
| Title | Abnormal left ventricular filling after neonatal repair of congenital heart disease: Association with increased mortality and morbidity |
| Sample | ||
|---|---|---|
| Population | neonates | |
| Source | cohort | |
| Region | NC, USA | |
| Method | echocardiograms and medical records | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | Aortic stenosis(Treatment) | Coarctation(Control) |
| Number | 1 | 4 |
| Age | 2 to 21 days (mean 11.3 ± 5.4 days) | 2 to 21 days (mean 11.3 ± 5.4 days) |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 1 | 4 |
